Clinical Trials for Chimeric Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Chimeric Therapeutics

Clinical Trials (2)

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

PHASE1/PHASE2Recruiting

135 participants

Started: May 15, 2024 · Completed: May 31, 2027

3 conditions1 sponsor4 locations

CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

PHASE1Active, not recruiting

42 participants

Started: Jun 6, 2023 · Completed: Jan 31, 2041

1 condition1 sponsor2 locations